Patients undergoing liver transplant have the potential to exhibit hyperglycemia due to insulin resistance [9] and the exogenous administration of steroids may make hypoglycemia less likely; it appears that aggressive insulin therapy is not associated with a greater risk of hypoglycemia compared to conventional control and can be managed safely during the intraoperative phase of liver transplantation. This evidence concerns the gene INS and Insulin resistance.